The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor.

@article{Won2012TheCB,
  title={The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor.},
  author={Jae Kyung Won and Hee Won Yang and Sung-Young Shin and Jong Hoon Lee and Won Heo and Kwang-Hyun Cho},
  journal={Journal of molecular cell biology},
  year={2012},
  volume={4 3},
  pages={153-63}
}
MEK inhibitor has been highlighted as a promising anti-tumor drug but its effect has been reported as varying over a wide range depending on patho-physiological conditions. In this study, we employed a systems approach by combining biochemical experimentation with in silico simulations to investigate the resistance mechanism and functional consequences of MEK inhibitor. To this end, we have developed an extended integrative model of ERK and PI3K signaling pathways by considering the crosstalk… CONTINUE READING